Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database
This study offers a more comprehensive understanding of tiotropium by uncovering previously unreported adverse reactions. Physicians should take these newly identified adverse reactions into account when prescribing this medication.
Authors
- Tianyuan Xin
- Yuyan Chen (ORCID: https://orcid.org/0000-0002-2894-1430)
- Changwen Chen
- Beiyi Xiang (ORCID: https://orcid.org/0009-0003-4601-300X)
- Lin Zhang (ORCID: https://orcid.org/0000-0001-5431-5006)
- Zhe Chen (ORCID: https://orcid.org/0000-0002-2919-4481)
- Rui Yang (ORCID: https://orcid.org/0000-0003-3525-1726)
Institutions
- Jiangsu University (CN)
- Soochow University (CN)
- Kunshan Govisionox Optoelectronic (China) (CN)
- First People's Hospital of Kunshan (CN)
- Changshu No.1 People's Hospital (CN)
Publication Details
- Journal
- Journal of Pharmacy & Pharmaceutical Sciences
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/jpps.2025.14917
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- Government of Jiangsu Province